Novel calcium channels and uses thereof

Details for Australian Patent Application No. 2004278282 (hide)

Owner Synta Pharmaceuticals Corp. Beth Israel Deaconess Medical Center, Inc.

Inventors Launay, Pierre; Kinet, Jean-Pierre; Mahiou, Jerome; Nadler, Monica J. S.

Agent Davies Collison Cave

Pub. Number AU-A-2004278282

PCT Pub. Number WO2005/033139

Priority 60/474,245 28.05.03 US

Filing date 28 May 2004

Wipo publication date 14 April 2005

International Classifications

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

Event Publications

12 January 2006 PCT application entered the National Phase

  PCT publication WO2005/033139 Priority application(s): WO2005/033139

5 June 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004278283-Conformal airliner defense (CAD) system

2004278276-New 2-substituted, 4-amino-thiazolo(4,5-d) pyrimidines, useful as chemokine receptor antagonists, esp. CX3CR1